Tivey, Ann
Britton, Fiona
Scott, Julie-Ann
Rothwell, Dominic
Lorigan, Paul
Lee, Rebecca http://orcid.org/0000-0003-2540-2009
Funding for this research was provided by:
cancer research uk (27405)
Article History
Accepted: 4 October 2021
First Online: 8 February 2022
Declarations
:
: Ann Tivey is supported by the National Institute for Health Research (NIHR) as an NIHR Academic Clinical Fellow.Fiona Britton declares that she has no conflict of interest.Julie-Ann Scott declares that she has no conflict of interest.Dominic Rothwell declares that she has no conflict of interest.Paul Lorigan has received clinical trial support from Bristol-Myers Squibb, Novartis, GlaxoSmithKline and Amgen; has received speaker’s honoraria from Bristol-Myers Squibb, Merck, GlaxoSmithKline, Chugai Pharmaceutical Co., Ltd, Laboratoires Pierre Fabre, NeraCare, Roche and Oncology Education Canada; and has received compensation for participation on advisory boards from Bristol-Myers Squibb, Merck, Novartis, GlaxoSmithKline, Amgen, Chugai Pharmaceutical Co., Ltd, Laboratoires Pierre Fabre, NeraCare, Roche and Oncology Education Canada.Rebecca Lee has received research funding from Bristol-Myers Squibb for the CAcTUS Trial, and has received speaker’s honoraria from AstraZeneca.